口腔鳞癌术后原发灶与淋巴结CTV勾画的ESTRO临床指南
欧洲放射肿瘤学会(ESTRO)召集多学科专家组,针对需术后放疗的口腔鳞状细胞癌(OCSCC),提出术后原发肿瘤和淋巴结临床靶区(CTV)勾画共识指南。指南建议在放疗计划扫描上重建代表切除原发灶和淋巴结大体肿瘤体积的替代体积(GTV-P、GTV-N),并以其几何外扩结合手术缺损和/或重建皮瓣几何外扩构成术后CTV-P,以替代GTV-N几何外扩结合受累淋巴结区构成CTV-N。指南还纳入预防剂量CTV(CTV-N2)中高危淋巴结区的勾画方法,以及单侧和/或双侧颈部治疗决策。
要点
- 术后CTV-P由替代GTV-P几何外扩与手术缺损和/或重建皮瓣几何外扩共同构成。
- 术后CTV-N由替代GTV-N几何外扩与受累淋巴结区(CTV-N1)共同构成。
- 指南纳入CTV-N2高危淋巴结区勾画方法及单侧和/或双侧颈部治疗决策。
核心结论
- 实施该指南应减少勾画差异,并通过促进方法一致性,便于开展含放疗质量保证(RTQA)的多机构审计和临床试验。
- 预计该指南将成为未来旨在标准化其他头颈部亚部位术后CTV勾画指南的基础。
研究设计与样本
- 由欧洲放射肿瘤学会(ESTRO)召集的多学科专家组制定,基于口腔鳞状细胞癌多学科管理原则并改编既往原发CTV勾画指南中的几何外扩方法。
- 新共识指南提出后,与国际第二梯队专家共享,以确保其全球可接受性和适用性。
主要发现
- 指南提出在放疗计划扫描上通过配准诊断影像或参考解剖标志,重建代表切除原发灶和淋巴结大体肿瘤体积的替代体积(GTV-P和GTV-N)。
- 术后原发肿瘤CTV(CTV-P)为复合体积,包括替代GTV-P周围几何外扩以及手术缺损和/或重建皮瓣周围几何外扩。
- 术后淋巴结区CTV(CTV-N)为复合体积,包括替代GTV-N周围几何外扩以及受累淋巴结区(CTV-N1)。
关键数值与推荐
- CTV-P构成:i)替代GTV-P周围几何外扩;ii)手术缺损和/或重建皮瓣周围几何外扩。
- CTV-N构成:i)替代GTV-N周围几何外扩;ii)受累淋巴结区(CTV-N1)。
- 指南包含预防剂量CTV(CTV-N2)中高危淋巴结区的勾画方法,以及单侧和/或双侧颈部治疗决策。
- 替代GTV-P和GTV-N的重建方式:与诊断影像配准或参考解剖标志。
临床怎么用
- 临床可将该指南用于口腔鳞状细胞癌术后放疗的原发灶和淋巴结CTV勾画,以减少个体、机构和国别间的勾画差异。
- 按指南重建替代GTV并构建复合CTV,有助于统一勾画方法并支持多机构审计和含RTQA的临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To date, no consensus guidelines have been published that systematically guide delineation of primary and nodal Clinical Target Volumes (CTVs) in patients who require post-operative radiotherapy (PORT) for mucosal Head and Neck squamous cell carcinoma (HNSCC). As a result, significant individual, institutional and national variation exists in the way that CTVs are delineated in the post-operative setting, leading to considerable heterogeneity in radiotherapy treatment. METHODS: A multi-disciplinary group of experts convened by the European Society for Radiotherapy and Oncology (ESTRO) set-out principles for the multi-disciplinary management of oral cavity squamous cell carcinoma (OCSCC). Building on these, and adapting the geometric expansion approach described in previous primary CTV delineation guidelines, new consensus guidelines for the delineation of post-operative CTVs, both for the primary tumour and nodal regions, were proposed by the expert group, before being shared with a second tier of international experts to ensure their worldwide acceptability and applicability. RESULTS: These guidelines propose that surrogate volumes representing the resected primary and nodal Gross Tumour Volumes (GTV-P and GTV-N respectively) are re-created on the radiotherapy planning scan, either by registration with diagnostic imaging or via reference to anatomical landmarks. A post-operative CTV for the primary tumour (CTV-P) is created as a composite volume that includes: i) geometric expansion around the surrogate GTV-P, and ii) geometric expansion around the surgical defect and/or reconstruction flap. A post-operative CTV for the nodal region (CTV-N) is created as a composite volume that includes: i) geometric expansion around the surrogate GTV-N, and ii) the involved nodal level (CTV-N1). Guidelines for delineating at-risk nodal levels in a prophylactic dose CTV (CTV-N2) are included, and for making decisions regarding the need for unilateral and/or bilateral neck treatment. CONCLUSIONS: Implementation of these guidelines into clinical practice should reduce variation, and by promoting consistency of approach, facilitate multi-institutional audits and clinical trials including Radiation Therapy Quality Assurance (RTQA) in patients with OCSCC. It is anticipated that they will form the basis for future guidelines aiming to standardise post-operative CTV delineation in other head and neck subsites.
引用
- Evans M, Bonomo P, Chan PC, et al. Delineation of the post-operative primary tumour and nodal clinical target volumes in oral cavity squamous cell carcinoma: European Society for Radiotherapy and Oncology (ESTRO) clinical guidelines. Radiother Oncol. 2025. PMID: 40925473. doi:10.1016/j.radonc.2025.111135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。